Who Paid My Doc
Hillary Gray
Nurse Practitioner, Psychiatric/Mental Health Rutland, VT Nurse Practitioner
NPI 1629437504 CMS profile 11065013
98 Allen St, Rutland, VT 05701
General payments
$70
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Hillary Gray of Rutland, VT is reported in the CMS Open Payments database as having received $70 across 3 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 15th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $18 | 1 | |
| 2022 | General | $33 | 1 | |
| 2021 | General | $19 | 1 |
Beside peers
- Hillary Gray
- Nurse Practitioner, Psychiatric/Mental Health median
- Middle half of Nurse Practitioner, Psychiatric/Mental Health
- National median
In program year 2025, general payments to Hillary Gray were reported at $0. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.
Show as a table
| Year | Hillary Gray | Nurse Practitioner, Psychiatric/Mental Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $19 | $166 | $54–$482 | $132 |
| 2022 | $33 | $195 | $66–$559 | $149 |
| 2023 | $18 | $233 | $82–$673 | $160 |
| 2024 | $0 | $236 | $84–$688 | $164 |
| 2025 | $0 | $258 | $93–$764 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 5 drugsPart D claims
82
Drug cost
$741
Branded share of claims
40.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | Brand | 22 | $309 | |
| Buprenorphine Hcl | Generic | 20 | $248 | |
| Quetiapine Fumarate | Generic | 13 | $124 | |
| Bupropion Xl Bupropion Hcl | Brand | 11 | $43 | |
| Gabapentin | Generic | 16 | $18 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Psychiatric/Mental Health in Vermont
Joshua Schupp-Star
Nurse Practitioner, Psychiatric/Mental Health · Burlington, VT
Jennifer Brennan
Nurse Practitioner, Psychiatric/Mental Health · Saint Albans, VT
Roanna Bamford
Nurse Practitioner, Psychiatric/Mental Health · St Johnsbury, VT
Jessica Porter
Nurse Practitioner, Psychiatric/Mental Health · Burlington, VT
Folake Azeez
Nurse Practitioner, Psychiatric/Mental Health · Rutland, VT
Julie Sullivan
Nurse Practitioner, Psychiatric/Mental Health · Morrisville, VT
Related records
Nurse Practitioner, Psychiatric/Mental Health in Vermont
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Psychiatric/Mental Health
Everyone recorded under this specialty, nationwide.
Doctors in Vermont
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.